Factors associated with inappropriate reduced doses of non-vita-min K antagonist oral anticoagulants in patients with atrial fibrillation [PDF]
, 2021 The objective was to study the factors associated with inappropriate reduced doses of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (AF) in real outpatient practice.Methods and materials.
E. I. Baranova +3 more
core +3 more sources
ПРОБЛЕМА ВНУТРИЧЕРЕПНЫХ КРОВОИЗЛИЯНИЙ НА ФОНЕ ПРИЕМА «НОВЫХ» АНТИ КОАГУЛЯНТОВ
Атеротромбоз, 2014 Высокая распространенность тромботических осложнений у пациентов с сердечно-сосудистыми заболеваниями обусловила широкое применение в клинической практике антикоагулянтной терапии. Длительное время основным антикоагулянтом, применяемым по этим показаниям,
doaj +1 more source
Endovascular treatment of acute occlusive mesenteric ischemia
Grekov's Bulletin of Surgery, 2019 В в е д е н и е. Острая мезентериальная ишемия (ОМИ) – ургентное состояние с летальностью до 70 % [1]. Современные подходы к лечению острой мезентериальной ишемии, наряду с возможностями ранней диагностики, позволяют снизить летальность при данном ...
A. Korolkov +3 more
semanticscholar +1 more source
Эффективность и безопасность пероральных антикоагулянтов при венозных тромбоэмболических осложнениях: непрямые сравнения [PDF]
, 2016 Objective. The aim was to perform an indirect comparisons of the effectiveness and safety of new oral anticoagulants (NOACs) in the management of venous thromboembolism (VTE).Material and methods.
A. S. Maslakov +11 more
core +2 more sources
Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review [PDF]
, 2022 The last decade has dramatically changed the strategy of anticoagulant therapy in patients with atrial fibrillation. Direct oral anticoagulants have replaced vitamin K antagonists: either direct thrombin blockers (dabigatran) or factor IIa blockers ...
B. A. Tatarsky, N. V. Kazennova
core +2 more sources
Рациональная фармакотерапия в кардиологии, 2015 Data on the problem of thromboembolic complications in non-valvular atrial fibrillation are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties in drug choice and dosage adjustment are also ...
E. L. Dolgova +2 more
doaj +1 more source
An Elderly Patient with Atrial Fibrillation: Ways to Enhance Safety of Anticoagulant Therapy
Doctor Ru, 2019 Цель обзора. Обсуждение возможностей применения одного из пероральных антикоагулянтов прямого действия — апиксабана — для профилактики инсульта и/или системных эмболий у пожилых пациентов с фибрилляцией предсердий. Основные положения.
N. Vorobyeva, O. Tkacheva, Russia Moscow
semanticscholar +1 more source
Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants [PDF]
, 2023 Left ventricular thrombus (LVT) is a serious risk factor for systemic embolism development. Despite the evident danger of this condition, current guidelines describe management of patients with this potentially fatal complication very briefly.
A. A. Sokolova +2 more
core +2 more sources
PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
Рациональная фармакотерапия в кардиологии, 2015 Apixaban is a "new" oral anticoagulant, direct Xa factor inhibitor with a good evidence base of the efficacy in the prevention of ischemic stroke in patients with atrial fibrillation.
D. A. Sychev +6 more
doaj +1 more source
Safety and Risk of Pharmacotherapy, 2019 New oral anticoagulants are effective for the prevention of thromboembolic complications in patients with atrial fibrillation, or after orthopedic surgery. The use of these drugs may be associated with the risk of bleeding from the gastrointestinal tract
A. Pereverzev +3 more
semanticscholar +1 more source